Global Intelligent Clinical Trials Market Growth (Status and Outlook) 2026-2032
The global Intelligent Clinical Trials market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Artificial intelligence can reduce clinical trial cycle times while improving the costs of productivity and outcomes of clinical development.
Global Intelligent Clinical Trials Market
The global intelligent clinical trials market refers to the market for advanced technologies and solutions that streamline and optimize the clinical trial processes. Intelligent clinical trials utilize innovative technologies, data analytics, and automation to enhance efficiency, reduce costs, improve patient recruitment and retention, and accelerate the drug development process.
Here are key aspects and components within the global intelligent clinical trials market:
Technology and Solutions: The market encompasses a wide range of technologies and solutions that revolutionize different stages of the clinical trial process. This includes electronic data capture (EDC) systems, electronic patient-reported outcomes (ePRO) platforms, remote monitoring tools, real-time data analytics, predictive analytics, artificial intelligence (AI), machine learning (ML), wearables, cloud computing, and blockchain technology. These technologies enable seamless data collection, analysis, and integration, enhancing the overall trial management and decision-making process.
Benefits and Advantages: Intelligent clinical trials offer numerous benefits over traditional methods, driving the market growth. These benefits include enhanced patient engagement and experience, improved trial design and protocols, optimized recruitment and retention strategies, real-time monitoring of patient safety data, faster data analysis and insights, reduced human errors, efficient site selection and management, better regulatory compliance, and overall cost and time savings in drug development.
Remote and Decentralized Trials: With the COVID-19 pandemic, there has been a significant shift towards remote and decentralized clinical trials. Intelligent solutions enable remote data collection, virtual patient visits, and monitoring, eliminating the need for patients to visit physical sites regularly. This approach improves patient convenience, expands geographic reach, increases patient participation, and reduces trial costs. Intelligent technologies facilitate remote patient monitoring, virtual site visits, and secure data transmission for decentralized trials.
Data Integration and Analytics: Intelligent clinical trials emphasize the integration and analysis of various data sources to derive meaningful insights. Advanced analytics and AI/ML algorithms help analyze vast amounts of clinical data, patient records, genetics, and real-world evidence to identify patterns, optimize trial outcomes, and predict patient responses. Real-time data analytics enable adaptive trial design, dynamic patient cohort identification, and rapid decision-making based on evolving trial data.
Regulatory Landscape and Standards: The market is influenced by regulatory frameworks and standards governing clinical trials globally. Regulatory bodies are increasingly recognizing the benefits of intelligent clinical trial technologies in improving trial efficiency and data quality. Efforts are being made to establish guidelines, data standards (such as CDISC), and cybersecurity regulations to ensure data integrity, patient privacy, and compliance during the implementation of intelligent solutions.
Collaboration and Partnerships: The intelligent clinical trials market involves collaborations between pharmaceutical companies, contract research organizations (CROs), technology providers, academic institutions, and healthcare providers. These collaborations aim to leverage domain expertise, technological capabilities, and data-sharing initiatives to develop and implement intelligent solutions effectively. Partnerships between technology providers and CROs help in the adoption of intelligent tools and platforms across the clinical trial ecosystem.
Market Dynamics: The market for intelligent clinical trials is driven by factors such as the increasing complexity and cost of traditional trials, the need for faster drug development, rising patient-centric approaches, advancements in digital health technologies, and the growing power of data analytics and AI. Additionally, the COVID-19 pandemic has accelerated the adoption of remote and decentralized trial models, further fueling the demand for intelligent solutions.
The global intelligent clinical trials market presents opportunities for technology providers to develop innovative solutions, expand their product portfolios, and enter strategic partnerships with pharmaceutical companies and CROs. However, challenges such as data privacy and security concerns, regulatory compliance, infrastructure limitations, and the need for skilled personnel in implementing intelligent technologies remain significant in the market.
Overall, the intelligent clinical trials market is driven by the increasing demand for efficient and patient-centric drug development processes and the integration of advanced technologies and data analytics to optimize trial outcomes. The market is poised for significant growth as pharmaceutical companies and research organizations embrace intelligent solutions to transform the clinical trial landscape.Global Intelligent Clinical Trials Market
The global intelligent clinical trials market refers to the market for advanced technologies and solutions that streamline and optimize the clinical trial processes. Intelligent clinical trials utilize innovative technologies, data analytics, and automation to enhance efficiency, reduce costs, improve patient recruitment and retention, and accelerate the drug development process.
Here are key aspects and components within the global intelligent clinical trials market:
Technology and Solutions: The market encompasses a wide range of technologies and solutions that revolutionize different stages of the clinical trial process. This includes electronic data capture (EDC) systems, electronic patient-reported outcomes (ePRO) platforms, remote monitoring tools, real-time data analytics, predictive analytics, artificial intelligence (AI), machine learning (ML), wearables, cloud computing, and blockchain technology. These technologies enable seamless data collection, analysis, and integration, enhancing the overall trial management and decision-making process.
Benefits and Advantages: Intelligent clinical trials offer numerous benefits over traditional methods, driving the market growth. These benefits include enhanced patient engagement and experience, improved trial design and protocols, optimized recruitment and retention strategies, real-time monitoring of patient safety data, faster data analysis and insights, reduced human errors, efficient site selection and management, better regulatory compliance, and overall cost and time savings in drug development.
Remote and Decentralized Trials: With the COVID-19 pandemic, there has been a significant shift towards remote and decentralized clinical trials. Intelligent solutions enable remote data collection, virtual patient visits, and monitoring, eliminating the need for patients to visit physical sites regularly. This approach improves patient convenience, expands geographic reach, increases patient participation, and reduces trial costs. Intelligent technologies facilitate remote patient monitoring, virtual site visits, and secure data transmission for decentralized trials.
Data Integration and Analytics: Intelligent clinical trials emphasize the integration and analysis of various data sources to derive meaningful insights. Advanced analytics and AI/ML algorithms help analyze vast amounts of clinical data, patient records, genetics, and real-world evidence to identify patterns, optimize trial outcomes, and predict patient responses. Real-time data analytics enable adaptive trial design, dynamic patient cohort identification, and rapid decision-making based on evolving trial data.
Regulatory Landscape and Standards: The market is influenced by regulatory frameworks and standards governing clinical trials globally. Regulatory bodies are increasingly recognizing the benefits of intelligent clinical trial technologies in improving trial efficiency and data quality. Efforts are being made to establish guidelines, data standards (such as CDISC), and cybersecurity regulations to ensure data integrity, patient privacy, and compliance during the implementation of intelligent solutions.
Collaboration and Partnerships: The intelligent clinical trials market involves collaborations between pharmaceutical companies, contract research organizations (CROs), technology providers, academic institutions, and healthcare providers. These collaborations aim to leverage domain expertise, technological capabilities, and data-sharing initiatives to develop and implement intelligent solutions effectively. Partnerships between technology providers and CROs help in the adoption of intelligent tools and platforms across the clinical trial ecosystem.
Market Dynamics: The market for intelligent clinical trials is driven by factors such as the increasing complexity and cost of traditional trials, the need for faster drug development, rising patient-centric approaches, advancements in digital health technologies, and the growing power of data analytics and AI. Additionally, the COVID-19 pandemic has accelerated the adoption of remote and decentralized trial models, further fueling the demand for intelligent solutions.
The global intelligent clinical trials market presents opportunities for technology providers to develop innovative solutions, expand their product portfolios, and enter strategic partnerships with pharmaceutical companies and CROs. However, challenges such as data privacy and security concerns, regulatory compliance, infrastructure limitations, and the need for skilled personnel in implementing intelligent technologies remain significant in the market.
Overall, the intelligent clinical trials market is driven by the increasing demand for efficient and patient-centric drug development processes and the integration of advanced technologies and data analytics to optimize trial outcomes. The market is poised for significant growth as pharmaceutical companies and research organizations embrace intelligent solutions to transform the clinical trial landscape.
LPI (LP Information)' newest research report, the “Intelligent Clinical Trials Industry Forecast” looks at past sales and reviews total world Intelligent Clinical Trials sales in 2025, providing a comprehensive analysis by region and market sector of projected Intelligent Clinical Trials sales for 2026 through 2032. With Intelligent Clinical Trials sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intelligent Clinical Trials industry.
This Insight Report provides a comprehensive analysis of the global Intelligent Clinical Trials landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Intelligent Clinical Trials portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intelligent Clinical Trials market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intelligent Clinical Trials and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intelligent Clinical Trials.
This report presents a comprehensive overview, market shares, and growth opportunities of Intelligent Clinical Trials market by product type, application, key players and key regions and countries.
Artificial intelligence can reduce clinical trial cycle times while improving the costs of productivity and outcomes of clinical development.
Global Intelligent Clinical Trials Market
The global intelligent clinical trials market refers to the market for advanced technologies and solutions that streamline and optimize the clinical trial processes. Intelligent clinical trials utilize innovative technologies, data analytics, and automation to enhance efficiency, reduce costs, improve patient recruitment and retention, and accelerate the drug development process.
Here are key aspects and components within the global intelligent clinical trials market:
Technology and Solutions: The market encompasses a wide range of technologies and solutions that revolutionize different stages of the clinical trial process. This includes electronic data capture (EDC) systems, electronic patient-reported outcomes (ePRO) platforms, remote monitoring tools, real-time data analytics, predictive analytics, artificial intelligence (AI), machine learning (ML), wearables, cloud computing, and blockchain technology. These technologies enable seamless data collection, analysis, and integration, enhancing the overall trial management and decision-making process.
Benefits and Advantages: Intelligent clinical trials offer numerous benefits over traditional methods, driving the market growth. These benefits include enhanced patient engagement and experience, improved trial design and protocols, optimized recruitment and retention strategies, real-time monitoring of patient safety data, faster data analysis and insights, reduced human errors, efficient site selection and management, better regulatory compliance, and overall cost and time savings in drug development.
Remote and Decentralized Trials: With the COVID-19 pandemic, there has been a significant shift towards remote and decentralized clinical trials. Intelligent solutions enable remote data collection, virtual patient visits, and monitoring, eliminating the need for patients to visit physical sites regularly. This approach improves patient convenience, expands geographic reach, increases patient participation, and reduces trial costs. Intelligent technologies facilitate remote patient monitoring, virtual site visits, and secure data transmission for decentralized trials.
Data Integration and Analytics: Intelligent clinical trials emphasize the integration and analysis of various data sources to derive meaningful insights. Advanced analytics and AI/ML algorithms help analyze vast amounts of clinical data, patient records, genetics, and real-world evidence to identify patterns, optimize trial outcomes, and predict patient responses. Real-time data analytics enable adaptive trial design, dynamic patient cohort identification, and rapid decision-making based on evolving trial data.
Regulatory Landscape and Standards: The market is influenced by regulatory frameworks and standards governing clinical trials globally. Regulatory bodies are increasingly recognizing the benefits of intelligent clinical trial technologies in improving trial efficiency and data quality. Efforts are being made to establish guidelines, data standards (such as CDISC), and cybersecurity regulations to ensure data integrity, patient privacy, and compliance during the implementation of intelligent solutions.
Collaboration and Partnerships: The intelligent clinical trials market involves collaborations between pharmaceutical companies, contract research organizations (CROs), technology providers, academic institutions, and healthcare providers. These collaborations aim to leverage domain expertise, technological capabilities, and data-sharing initiatives to develop and implement intelligent solutions effectively. Partnerships between technology providers and CROs help in the adoption of intelligent tools and platforms across the clinical trial ecosystem.
Market Dynamics: The market for intelligent clinical trials is driven by factors such as the increasing complexity and cost of traditional trials, the need for faster drug development, rising patient-centric approaches, advancements in digital health technologies, and the growing power of data analytics and AI. Additionally, the COVID-19 pandemic has accelerated the adoption of remote and decentralized trial models, further fueling the demand for intelligent solutions.
The global intelligent clinical trials market presents opportunities for technology providers to develop innovative solutions, expand their product portfolios, and enter strategic partnerships with pharmaceutical companies and CROs. However, challenges such as data privacy and security concerns, regulatory compliance, infrastructure limitations, and the need for skilled personnel in implementing intelligent technologies remain significant in the market.
Overall, the intelligent clinical trials market is driven by the increasing demand for efficient and patient-centric drug development processes and the integration of advanced technologies and data analytics to optimize trial outcomes. The market is poised for significant growth as pharmaceutical companies and research organizations embrace intelligent solutions to transform the clinical trial landscape.Global Intelligent Clinical Trials Market
The global intelligent clinical trials market refers to the market for advanced technologies and solutions that streamline and optimize the clinical trial processes. Intelligent clinical trials utilize innovative technologies, data analytics, and automation to enhance efficiency, reduce costs, improve patient recruitment and retention, and accelerate the drug development process.
Here are key aspects and components within the global intelligent clinical trials market:
Technology and Solutions: The market encompasses a wide range of technologies and solutions that revolutionize different stages of the clinical trial process. This includes electronic data capture (EDC) systems, electronic patient-reported outcomes (ePRO) platforms, remote monitoring tools, real-time data analytics, predictive analytics, artificial intelligence (AI), machine learning (ML), wearables, cloud computing, and blockchain technology. These technologies enable seamless data collection, analysis, and integration, enhancing the overall trial management and decision-making process.
Benefits and Advantages: Intelligent clinical trials offer numerous benefits over traditional methods, driving the market growth. These benefits include enhanced patient engagement and experience, improved trial design and protocols, optimized recruitment and retention strategies, real-time monitoring of patient safety data, faster data analysis and insights, reduced human errors, efficient site selection and management, better regulatory compliance, and overall cost and time savings in drug development.
Remote and Decentralized Trials: With the COVID-19 pandemic, there has been a significant shift towards remote and decentralized clinical trials. Intelligent solutions enable remote data collection, virtual patient visits, and monitoring, eliminating the need for patients to visit physical sites regularly. This approach improves patient convenience, expands geographic reach, increases patient participation, and reduces trial costs. Intelligent technologies facilitate remote patient monitoring, virtual site visits, and secure data transmission for decentralized trials.
Data Integration and Analytics: Intelligent clinical trials emphasize the integration and analysis of various data sources to derive meaningful insights. Advanced analytics and AI/ML algorithms help analyze vast amounts of clinical data, patient records, genetics, and real-world evidence to identify patterns, optimize trial outcomes, and predict patient responses. Real-time data analytics enable adaptive trial design, dynamic patient cohort identification, and rapid decision-making based on evolving trial data.
Regulatory Landscape and Standards: The market is influenced by regulatory frameworks and standards governing clinical trials globally. Regulatory bodies are increasingly recognizing the benefits of intelligent clinical trial technologies in improving trial efficiency and data quality. Efforts are being made to establish guidelines, data standards (such as CDISC), and cybersecurity regulations to ensure data integrity, patient privacy, and compliance during the implementation of intelligent solutions.
Collaboration and Partnerships: The intelligent clinical trials market involves collaborations between pharmaceutical companies, contract research organizations (CROs), technology providers, academic institutions, and healthcare providers. These collaborations aim to leverage domain expertise, technological capabilities, and data-sharing initiatives to develop and implement intelligent solutions effectively. Partnerships between technology providers and CROs help in the adoption of intelligent tools and platforms across the clinical trial ecosystem.
Market Dynamics: The market for intelligent clinical trials is driven by factors such as the increasing complexity and cost of traditional trials, the need for faster drug development, rising patient-centric approaches, advancements in digital health technologies, and the growing power of data analytics and AI. Additionally, the COVID-19 pandemic has accelerated the adoption of remote and decentralized trial models, further fueling the demand for intelligent solutions.
The global intelligent clinical trials market presents opportunities for technology providers to develop innovative solutions, expand their product portfolios, and enter strategic partnerships with pharmaceutical companies and CROs. However, challenges such as data privacy and security concerns, regulatory compliance, infrastructure limitations, and the need for skilled personnel in implementing intelligent technologies remain significant in the market.
Overall, the intelligent clinical trials market is driven by the increasing demand for efficient and patient-centric drug development processes and the integration of advanced technologies and data analytics to optimize trial outcomes. The market is poised for significant growth as pharmaceutical companies and research organizations embrace intelligent solutions to transform the clinical trial landscape.
LPI (LP Information)' newest research report, the “Intelligent Clinical Trials Industry Forecast” looks at past sales and reviews total world Intelligent Clinical Trials sales in 2025, providing a comprehensive analysis by region and market sector of projected Intelligent Clinical Trials sales for 2026 through 2032. With Intelligent Clinical Trials sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intelligent Clinical Trials industry.
This Insight Report provides a comprehensive analysis of the global Intelligent Clinical Trials landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Intelligent Clinical Trials portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intelligent Clinical Trials market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intelligent Clinical Trials and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intelligent Clinical Trials.
This report presents a comprehensive overview, market shares, and growth opportunities of Intelligent Clinical Trials market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Interventional
- Observational
- Expanded Access
- Others
Segmentation by Application:
- Autoimmune/Inflammation
- Pain Management
- Oncology
- Central Nervous System (CNS) Condition
- Diabetes
- Obesity
- Cardiovascular
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cerner Corporation
- GE Healthcare
- Koninklijke Philips N.V.
- Cognizant
- McKesson Corporation
- Athenahealth
- Veradigm
- Navitas Life Sciences
- Medidata Acorn AI
- Accenture
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intelligent Clinical Trials Market Size (2021-2032)
2.1.2 Intelligent Clinical Trials Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Intelligent Clinical Trials by Country/Region (2021, 2025 & 2032)
2.2 Intelligent Clinical Trials Segment by Type
2.2.1 Interventional
2.2.2 Observational
2.2.3 Expanded Access
2.2.4 Others
2.2.5 Intelligent Clinical Trials Market Size by Type
2.2.5.1 Intelligent Clinical Trials Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Intelligent Clinical Trials Market Size Market Share by Type (2021-2026)
2.3 Intelligent Clinical Trials Segment by Application
2.3.1 Autoimmune/Inflammation
2.3.2 Pain Management
2.3.3 Oncology
2.3.4 Central Nervous System (CNS) Condition
2.3.5 Diabetes
2.3.6 Obesity
2.3.7 Cardiovascular
2.3.8 Others
2.3.9 Intelligent Clinical Trials Market Size by Application
2.3.9.1 Intelligent Clinical Trials Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.9.2 Global Intelligent Clinical Trials Market Size Market Share by Application (2021-2026)
3 INTELLIGENT CLINICAL TRIALS MARKET SIZE BY PLAYER
3.1 Intelligent Clinical Trials Market Size Market Share by Player
3.1.1 Global Intelligent Clinical Trials Revenue by Player (2021-2026)
3.1.2 Global Intelligent Clinical Trials Revenue Market Share by Player (2021-2026)
3.2 Global Intelligent Clinical Trials Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INTELLIGENT CLINICAL TRIALS BY REGION
4.1 Intelligent Clinical Trials Market Size by Region (2021-2026)
4.2 Global Intelligent Clinical Trials Annual Revenue by Country/Region (2021-2026)
4.3 Americas Intelligent Clinical Trials Market Size Growth (2021-2026)
4.4 APAC Intelligent Clinical Trials Market Size Growth (2021-2026)
4.5 Europe Intelligent Clinical Trials Market Size Growth (2021-2026)
4.6 Middle East & Africa Intelligent Clinical Trials Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Intelligent Clinical Trials Market Size by Country (2021-2026)
5.2 Americas Intelligent Clinical Trials Market Size by Type (2021-2026)
5.3 Americas Intelligent Clinical Trials Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intelligent Clinical Trials Market Size by Region (2021-2026)
6.2 APAC Intelligent Clinical Trials Market Size by Type (2021-2026)
6.3 APAC Intelligent Clinical Trials Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Intelligent Clinical Trials Market Size by Country (2021-2026)
7.2 Europe Intelligent Clinical Trials Market Size by Type (2021-2026)
7.3 Europe Intelligent Clinical Trials Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intelligent Clinical Trials by Region (2021-2026)
8.2 Middle East & Africa Intelligent Clinical Trials Market Size by Type (2021-2026)
8.3 Middle East & Africa Intelligent Clinical Trials Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INTELLIGENT CLINICAL TRIALS MARKET FORECAST
10.1 Global Intelligent Clinical Trials Forecast by Region (2027-2032)
10.1.1 Global Intelligent Clinical Trials Forecast by Region (2027-2032)
10.1.2 Americas Intelligent Clinical Trials Forecast
10.1.3 APAC Intelligent Clinical Trials Forecast
10.1.4 Europe Intelligent Clinical Trials Forecast
10.1.5 Middle East & Africa Intelligent Clinical Trials Forecast
10.2 Americas Intelligent Clinical Trials Forecast by Country (2027-2032)
10.2.1 United States Market Intelligent Clinical Trials Forecast
10.2.2 Canada Market Intelligent Clinical Trials Forecast
10.2.3 Mexico Market Intelligent Clinical Trials Forecast
10.2.4 Brazil Market Intelligent Clinical Trials Forecast
10.3 APAC Intelligent Clinical Trials Forecast by Region (2027-2032)
10.3.1 China Intelligent Clinical Trials Market Forecast
10.3.2 Japan Market Intelligent Clinical Trials Forecast
10.3.3 Korea Market Intelligent Clinical Trials Forecast
10.3.4 Southeast Asia Market Intelligent Clinical Trials Forecast
10.3.5 India Market Intelligent Clinical Trials Forecast
10.3.6 Australia Market Intelligent Clinical Trials Forecast
10.4 Europe Intelligent Clinical Trials Forecast by Country (2027-2032)
10.4.1 Germany Market Intelligent Clinical Trials Forecast
10.4.2 France Market Intelligent Clinical Trials Forecast
10.4.3 UK Market Intelligent Clinical Trials Forecast
10.4.4 Italy Market Intelligent Clinical Trials Forecast
10.4.5 Russia Market Intelligent Clinical Trials Forecast
10.5 Middle East & Africa Intelligent Clinical Trials Forecast by Region (2027-2032)
10.5.1 Egypt Market Intelligent Clinical Trials Forecast
10.5.2 South Africa Market Intelligent Clinical Trials Forecast
10.5.3 Israel Market Intelligent Clinical Trials Forecast
10.5.4 Turkey Market Intelligent Clinical Trials Forecast
10.6 Global Intelligent Clinical Trials Forecast by Type (2027-2032)
10.7 Global Intelligent Clinical Trials Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Intelligent Clinical Trials Forecast
11 KEY PLAYERS ANALYSIS
11.1 Cerner Corporation
11.1.1 Cerner Corporation Company Information
11.1.2 Cerner Corporation Intelligent Clinical Trials Product Offered
11.1.3 Cerner Corporation Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Cerner Corporation Main Business Overview
11.1.5 Cerner Corporation Latest Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Company Information
11.2.2 GE Healthcare Intelligent Clinical Trials Product Offered
11.2.3 GE Healthcare Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 GE Healthcare Main Business Overview
11.2.5 GE Healthcare Latest Developments
11.3 Koninklijke Philips N.V.
11.3.1 Koninklijke Philips N.V. Company Information
11.3.2 Koninklijke Philips N.V. Intelligent Clinical Trials Product Offered
11.3.3 Koninklijke Philips N.V. Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Koninklijke Philips N.V. Main Business Overview
11.3.5 Koninklijke Philips N.V. Latest Developments
11.4 Cognizant
11.4.1 Cognizant Company Information
11.4.2 Cognizant Intelligent Clinical Trials Product Offered
11.4.3 Cognizant Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Cognizant Main Business Overview
11.4.5 Cognizant Latest Developments
11.5 McKesson Corporation
11.5.1 McKesson Corporation Company Information
11.5.2 McKesson Corporation Intelligent Clinical Trials Product Offered
11.5.3 McKesson Corporation Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 McKesson Corporation Main Business Overview
11.5.5 McKesson Corporation Latest Developments
11.6 Athenahealth
11.6.1 Athenahealth Company Information
11.6.2 Athenahealth Intelligent Clinical Trials Product Offered
11.6.3 Athenahealth Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Athenahealth Main Business Overview
11.6.5 Athenahealth Latest Developments
11.7 Veradigm
11.7.1 Veradigm Company Information
11.7.2 Veradigm Intelligent Clinical Trials Product Offered
11.7.3 Veradigm Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Veradigm Main Business Overview
11.7.5 Veradigm Latest Developments
11.8 Navitas Life Sciences
11.8.1 Navitas Life Sciences Company Information
11.8.2 Navitas Life Sciences Intelligent Clinical Trials Product Offered
11.8.3 Navitas Life Sciences Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Navitas Life Sciences Main Business Overview
11.8.5 Navitas Life Sciences Latest Developments
11.9 Medidata Acorn AI
11.9.1 Medidata Acorn AI Company Information
11.9.2 Medidata Acorn AI Intelligent Clinical Trials Product Offered
11.9.3 Medidata Acorn AI Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Medidata Acorn AI Main Business Overview
11.9.5 Medidata Acorn AI Latest Developments
11.10 Accenture
11.10.1 Accenture Company Information
11.10.2 Accenture Intelligent Clinical Trials Product Offered
11.10.3 Accenture Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Accenture Main Business Overview
11.10.5 Accenture Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intelligent Clinical Trials Market Size (2021-2032)
2.1.2 Intelligent Clinical Trials Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Intelligent Clinical Trials by Country/Region (2021, 2025 & 2032)
2.2 Intelligent Clinical Trials Segment by Type
2.2.1 Interventional
2.2.2 Observational
2.2.3 Expanded Access
2.2.4 Others
2.2.5 Intelligent Clinical Trials Market Size by Type
2.2.5.1 Intelligent Clinical Trials Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Intelligent Clinical Trials Market Size Market Share by Type (2021-2026)
2.3 Intelligent Clinical Trials Segment by Application
2.3.1 Autoimmune/Inflammation
2.3.2 Pain Management
2.3.3 Oncology
2.3.4 Central Nervous System (CNS) Condition
2.3.5 Diabetes
2.3.6 Obesity
2.3.7 Cardiovascular
2.3.8 Others
2.3.9 Intelligent Clinical Trials Market Size by Application
2.3.9.1 Intelligent Clinical Trials Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.9.2 Global Intelligent Clinical Trials Market Size Market Share by Application (2021-2026)
3 INTELLIGENT CLINICAL TRIALS MARKET SIZE BY PLAYER
3.1 Intelligent Clinical Trials Market Size Market Share by Player
3.1.1 Global Intelligent Clinical Trials Revenue by Player (2021-2026)
3.1.2 Global Intelligent Clinical Trials Revenue Market Share by Player (2021-2026)
3.2 Global Intelligent Clinical Trials Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INTELLIGENT CLINICAL TRIALS BY REGION
4.1 Intelligent Clinical Trials Market Size by Region (2021-2026)
4.2 Global Intelligent Clinical Trials Annual Revenue by Country/Region (2021-2026)
4.3 Americas Intelligent Clinical Trials Market Size Growth (2021-2026)
4.4 APAC Intelligent Clinical Trials Market Size Growth (2021-2026)
4.5 Europe Intelligent Clinical Trials Market Size Growth (2021-2026)
4.6 Middle East & Africa Intelligent Clinical Trials Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Intelligent Clinical Trials Market Size by Country (2021-2026)
5.2 Americas Intelligent Clinical Trials Market Size by Type (2021-2026)
5.3 Americas Intelligent Clinical Trials Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intelligent Clinical Trials Market Size by Region (2021-2026)
6.2 APAC Intelligent Clinical Trials Market Size by Type (2021-2026)
6.3 APAC Intelligent Clinical Trials Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Intelligent Clinical Trials Market Size by Country (2021-2026)
7.2 Europe Intelligent Clinical Trials Market Size by Type (2021-2026)
7.3 Europe Intelligent Clinical Trials Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intelligent Clinical Trials by Region (2021-2026)
8.2 Middle East & Africa Intelligent Clinical Trials Market Size by Type (2021-2026)
8.3 Middle East & Africa Intelligent Clinical Trials Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INTELLIGENT CLINICAL TRIALS MARKET FORECAST
10.1 Global Intelligent Clinical Trials Forecast by Region (2027-2032)
10.1.1 Global Intelligent Clinical Trials Forecast by Region (2027-2032)
10.1.2 Americas Intelligent Clinical Trials Forecast
10.1.3 APAC Intelligent Clinical Trials Forecast
10.1.4 Europe Intelligent Clinical Trials Forecast
10.1.5 Middle East & Africa Intelligent Clinical Trials Forecast
10.2 Americas Intelligent Clinical Trials Forecast by Country (2027-2032)
10.2.1 United States Market Intelligent Clinical Trials Forecast
10.2.2 Canada Market Intelligent Clinical Trials Forecast
10.2.3 Mexico Market Intelligent Clinical Trials Forecast
10.2.4 Brazil Market Intelligent Clinical Trials Forecast
10.3 APAC Intelligent Clinical Trials Forecast by Region (2027-2032)
10.3.1 China Intelligent Clinical Trials Market Forecast
10.3.2 Japan Market Intelligent Clinical Trials Forecast
10.3.3 Korea Market Intelligent Clinical Trials Forecast
10.3.4 Southeast Asia Market Intelligent Clinical Trials Forecast
10.3.5 India Market Intelligent Clinical Trials Forecast
10.3.6 Australia Market Intelligent Clinical Trials Forecast
10.4 Europe Intelligent Clinical Trials Forecast by Country (2027-2032)
10.4.1 Germany Market Intelligent Clinical Trials Forecast
10.4.2 France Market Intelligent Clinical Trials Forecast
10.4.3 UK Market Intelligent Clinical Trials Forecast
10.4.4 Italy Market Intelligent Clinical Trials Forecast
10.4.5 Russia Market Intelligent Clinical Trials Forecast
10.5 Middle East & Africa Intelligent Clinical Trials Forecast by Region (2027-2032)
10.5.1 Egypt Market Intelligent Clinical Trials Forecast
10.5.2 South Africa Market Intelligent Clinical Trials Forecast
10.5.3 Israel Market Intelligent Clinical Trials Forecast
10.5.4 Turkey Market Intelligent Clinical Trials Forecast
10.6 Global Intelligent Clinical Trials Forecast by Type (2027-2032)
10.7 Global Intelligent Clinical Trials Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Intelligent Clinical Trials Forecast
11 KEY PLAYERS ANALYSIS
11.1 Cerner Corporation
11.1.1 Cerner Corporation Company Information
11.1.2 Cerner Corporation Intelligent Clinical Trials Product Offered
11.1.3 Cerner Corporation Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Cerner Corporation Main Business Overview
11.1.5 Cerner Corporation Latest Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Company Information
11.2.2 GE Healthcare Intelligent Clinical Trials Product Offered
11.2.3 GE Healthcare Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 GE Healthcare Main Business Overview
11.2.5 GE Healthcare Latest Developments
11.3 Koninklijke Philips N.V.
11.3.1 Koninklijke Philips N.V. Company Information
11.3.2 Koninklijke Philips N.V. Intelligent Clinical Trials Product Offered
11.3.3 Koninklijke Philips N.V. Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Koninklijke Philips N.V. Main Business Overview
11.3.5 Koninklijke Philips N.V. Latest Developments
11.4 Cognizant
11.4.1 Cognizant Company Information
11.4.2 Cognizant Intelligent Clinical Trials Product Offered
11.4.3 Cognizant Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Cognizant Main Business Overview
11.4.5 Cognizant Latest Developments
11.5 McKesson Corporation
11.5.1 McKesson Corporation Company Information
11.5.2 McKesson Corporation Intelligent Clinical Trials Product Offered
11.5.3 McKesson Corporation Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 McKesson Corporation Main Business Overview
11.5.5 McKesson Corporation Latest Developments
11.6 Athenahealth
11.6.1 Athenahealth Company Information
11.6.2 Athenahealth Intelligent Clinical Trials Product Offered
11.6.3 Athenahealth Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Athenahealth Main Business Overview
11.6.5 Athenahealth Latest Developments
11.7 Veradigm
11.7.1 Veradigm Company Information
11.7.2 Veradigm Intelligent Clinical Trials Product Offered
11.7.3 Veradigm Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Veradigm Main Business Overview
11.7.5 Veradigm Latest Developments
11.8 Navitas Life Sciences
11.8.1 Navitas Life Sciences Company Information
11.8.2 Navitas Life Sciences Intelligent Clinical Trials Product Offered
11.8.3 Navitas Life Sciences Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Navitas Life Sciences Main Business Overview
11.8.5 Navitas Life Sciences Latest Developments
11.9 Medidata Acorn AI
11.9.1 Medidata Acorn AI Company Information
11.9.2 Medidata Acorn AI Intelligent Clinical Trials Product Offered
11.9.3 Medidata Acorn AI Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Medidata Acorn AI Main Business Overview
11.9.5 Medidata Acorn AI Latest Developments
11.10 Accenture
11.10.1 Accenture Company Information
11.10.2 Accenture Intelligent Clinical Trials Product Offered
11.10.3 Accenture Intelligent Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Accenture Main Business Overview
11.10.5 Accenture Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Intelligent Clinical Trials Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Intelligent Clinical Trials Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Interventional
Table 4. Major Players of Observational
Table 5. Major Players of Expanded Access
Table 6. Major Players of Others
Table 7. Intelligent Clinical Trials Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Intelligent Clinical Trials Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Intelligent Clinical Trials Market Size Market Share by Type (2021-2026)
Table 10. Intelligent Clinical Trials Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Intelligent Clinical Trials Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Intelligent Clinical Trials Market Size Market Share by Application (2021-2026)
Table 13. Global Intelligent Clinical Trials Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Intelligent Clinical Trials Revenue Market Share by Player (2021-2026)
Table 15. Intelligent Clinical Trials Key Players Head office and Products Offered
Table 16. Intelligent Clinical Trials Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Intelligent Clinical Trials Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Intelligent Clinical Trials Market Size Market Share by Region (2021-2026)
Table 21. Global Intelligent Clinical Trials Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Intelligent Clinical Trials Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Intelligent Clinical Trials Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Intelligent Clinical Trials Market Size Market Share by Country (2021-2026)
Table 25. Americas Intelligent Clinical Trials Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Intelligent Clinical Trials Market Size Market Share by Type (2021-2026)
Table 27. Americas Intelligent Clinical Trials Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Intelligent Clinical Trials Market Size Market Share by Application (2021-2026)
Table 29. APAC Intelligent Clinical Trials Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Intelligent Clinical Trials Market Size Market Share by Region (2021-2026)
Table 31. APAC Intelligent Clinical Trials Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Intelligent Clinical Trials Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Intelligent Clinical Trials Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Intelligent Clinical Trials Market Size Market Share by Country (2021-2026)
Table 35. Europe Intelligent Clinical Trials Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Intelligent Clinical Trials Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Intelligent Clinical Trials Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Intelligent Clinical Trials Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Intelligent Clinical Trials Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Intelligent Clinical Trials
Table 41. Key Market Challenges & Risks of Intelligent Clinical Trials
Table 42. Key Industry Trends of Intelligent Clinical Trials
Table 43. Global Intelligent Clinical Trials Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Intelligent Clinical Trials Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Intelligent Clinical Trials Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Intelligent Clinical Trials Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Cerner Corporation Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 48. Cerner Corporation Intelligent Clinical Trials Product Offered
Table 49. Cerner Corporation Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Cerner Corporation Main Business
Table 51. Cerner Corporation Latest Developments
Table 52. GE Healthcare Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 53. GE Healthcare Intelligent Clinical Trials Product Offered
Table 54. GE Healthcare Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. GE Healthcare Main Business
Table 56. GE Healthcare Latest Developments
Table 57. Koninklijke Philips N.V. Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 58. Koninklijke Philips N.V. Intelligent Clinical Trials Product Offered
Table 59. Koninklijke Philips N.V. Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Koninklijke Philips N.V. Main Business
Table 61. Koninklijke Philips N.V. Latest Developments
Table 62. Cognizant Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 63. Cognizant Intelligent Clinical Trials Product Offered
Table 64. Cognizant Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Cognizant Main Business
Table 66. Cognizant Latest Developments
Table 67. McKesson Corporation Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 68. McKesson Corporation Intelligent Clinical Trials Product Offered
Table 69. McKesson Corporation Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. McKesson Corporation Main Business
Table 71. McKesson Corporation Latest Developments
Table 72. Athenahealth Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 73. Athenahealth Intelligent Clinical Trials Product Offered
Table 74. Athenahealth Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Athenahealth Main Business
Table 76. Athenahealth Latest Developments
Table 77. Veradigm Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 78. Veradigm Intelligent Clinical Trials Product Offered
Table 79. Veradigm Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Veradigm Main Business
Table 81. Veradigm Latest Developments
Table 82. Navitas Life Sciences Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 83. Navitas Life Sciences Intelligent Clinical Trials Product Offered
Table 84. Navitas Life Sciences Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Navitas Life Sciences Main Business
Table 86. Navitas Life Sciences Latest Developments
Table 87. Medidata Acorn AI Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 88. Medidata Acorn AI Intelligent Clinical Trials Product Offered
Table 89. Medidata Acorn AI Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Medidata Acorn AI Main Business
Table 91. Medidata Acorn AI Latest Developments
Table 92. Accenture Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 93. Accenture Intelligent Clinical Trials Product Offered
Table 94. Accenture Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Accenture Main Business
Table 96. Accenture Latest Developments
Table 1. Intelligent Clinical Trials Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Intelligent Clinical Trials Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Interventional
Table 4. Major Players of Observational
Table 5. Major Players of Expanded Access
Table 6. Major Players of Others
Table 7. Intelligent Clinical Trials Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Intelligent Clinical Trials Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Intelligent Clinical Trials Market Size Market Share by Type (2021-2026)
Table 10. Intelligent Clinical Trials Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Intelligent Clinical Trials Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Intelligent Clinical Trials Market Size Market Share by Application (2021-2026)
Table 13. Global Intelligent Clinical Trials Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Intelligent Clinical Trials Revenue Market Share by Player (2021-2026)
Table 15. Intelligent Clinical Trials Key Players Head office and Products Offered
Table 16. Intelligent Clinical Trials Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Intelligent Clinical Trials Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Intelligent Clinical Trials Market Size Market Share by Region (2021-2026)
Table 21. Global Intelligent Clinical Trials Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Intelligent Clinical Trials Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Intelligent Clinical Trials Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Intelligent Clinical Trials Market Size Market Share by Country (2021-2026)
Table 25. Americas Intelligent Clinical Trials Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Intelligent Clinical Trials Market Size Market Share by Type (2021-2026)
Table 27. Americas Intelligent Clinical Trials Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Intelligent Clinical Trials Market Size Market Share by Application (2021-2026)
Table 29. APAC Intelligent Clinical Trials Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Intelligent Clinical Trials Market Size Market Share by Region (2021-2026)
Table 31. APAC Intelligent Clinical Trials Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Intelligent Clinical Trials Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Intelligent Clinical Trials Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Intelligent Clinical Trials Market Size Market Share by Country (2021-2026)
Table 35. Europe Intelligent Clinical Trials Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Intelligent Clinical Trials Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Intelligent Clinical Trials Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Intelligent Clinical Trials Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Intelligent Clinical Trials Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Intelligent Clinical Trials
Table 41. Key Market Challenges & Risks of Intelligent Clinical Trials
Table 42. Key Industry Trends of Intelligent Clinical Trials
Table 43. Global Intelligent Clinical Trials Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Intelligent Clinical Trials Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Intelligent Clinical Trials Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Intelligent Clinical Trials Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Cerner Corporation Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 48. Cerner Corporation Intelligent Clinical Trials Product Offered
Table 49. Cerner Corporation Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Cerner Corporation Main Business
Table 51. Cerner Corporation Latest Developments
Table 52. GE Healthcare Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 53. GE Healthcare Intelligent Clinical Trials Product Offered
Table 54. GE Healthcare Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. GE Healthcare Main Business
Table 56. GE Healthcare Latest Developments
Table 57. Koninklijke Philips N.V. Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 58. Koninklijke Philips N.V. Intelligent Clinical Trials Product Offered
Table 59. Koninklijke Philips N.V. Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Koninklijke Philips N.V. Main Business
Table 61. Koninklijke Philips N.V. Latest Developments
Table 62. Cognizant Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 63. Cognizant Intelligent Clinical Trials Product Offered
Table 64. Cognizant Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Cognizant Main Business
Table 66. Cognizant Latest Developments
Table 67. McKesson Corporation Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 68. McKesson Corporation Intelligent Clinical Trials Product Offered
Table 69. McKesson Corporation Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. McKesson Corporation Main Business
Table 71. McKesson Corporation Latest Developments
Table 72. Athenahealth Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 73. Athenahealth Intelligent Clinical Trials Product Offered
Table 74. Athenahealth Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Athenahealth Main Business
Table 76. Athenahealth Latest Developments
Table 77. Veradigm Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 78. Veradigm Intelligent Clinical Trials Product Offered
Table 79. Veradigm Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Veradigm Main Business
Table 81. Veradigm Latest Developments
Table 82. Navitas Life Sciences Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 83. Navitas Life Sciences Intelligent Clinical Trials Product Offered
Table 84. Navitas Life Sciences Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Navitas Life Sciences Main Business
Table 86. Navitas Life Sciences Latest Developments
Table 87. Medidata Acorn AI Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 88. Medidata Acorn AI Intelligent Clinical Trials Product Offered
Table 89. Medidata Acorn AI Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Medidata Acorn AI Main Business
Table 91. Medidata Acorn AI Latest Developments
Table 92. Accenture Details, Company Type, Intelligent Clinical Trials Area Served and Its Competitors
Table 93. Accenture Intelligent Clinical Trials Product Offered
Table 94. Accenture Intelligent Clinical Trials Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Accenture Main Business
Table 96. Accenture Latest Developments
LIST OF FIGURES
Figure 1. Intelligent Clinical Trials Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Intelligent Clinical Trials Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Intelligent Clinical Trials Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Intelligent Clinical Trials Sales Market Share by Country/Region (2025)
Figure 8. Intelligent Clinical Trials Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Intelligent Clinical Trials Market Size Market Share by Type in 2025
Figure 10. Intelligent Clinical Trials in Autoimmune/Inflammation
Figure 11. Global Intelligent Clinical Trials Market: Autoimmune/Inflammation (2021-2026) & ($ millions)
Figure 12. Intelligent Clinical Trials in Pain Management
Figure 13. Global Intelligent Clinical Trials Market: Pain Management (2021-2026) & ($ millions)
Figure 14. Intelligent Clinical Trials in Oncology
Figure 15. Global Intelligent Clinical Trials Market: Oncology (2021-2026) & ($ millions)
Figure 16. Intelligent Clinical Trials in Central Nervous System (CNS) Condition
Figure 17. Global Intelligent Clinical Trials Market: Central Nervous System (CNS) Condition (2021-2026) & ($ millions)
Figure 18. Intelligent Clinical Trials in Diabetes
Figure 19. Global Intelligent Clinical Trials Market: Diabetes (2021-2026) & ($ millions)
Figure 20. Intelligent Clinical Trials in Obesity
Figure 21. Global Intelligent Clinical Trials Market: Obesity (2021-2026) & ($ millions)
Figure 22. Intelligent Clinical Trials in Cardiovascular
Figure 23. Global Intelligent Clinical Trials Market: Cardiovascular (2021-2026) & ($ millions)
Figure 24. Intelligent Clinical Trials in Others
Figure 25. Global Intelligent Clinical Trials Market: Others (2021-2026) & ($ millions)
Figure 26. Global Intelligent Clinical Trials Market Size Market Share by Application in 2025
Figure 27. Global Intelligent Clinical Trials Revenue Market Share by Player in 2025
Figure 28. Global Intelligent Clinical Trials Market Size Market Share by Region (2021-2026)
Figure 29. Americas Intelligent Clinical Trials Market Size 2021-2026 ($ millions)
Figure 30. APAC Intelligent Clinical Trials Market Size 2021-2026 ($ millions)
Figure 31. Europe Intelligent Clinical Trials Market Size 2021-2026 ($ millions)
Figure 32. Middle East & Africa Intelligent Clinical Trials Market Size 2021-2026 ($ millions)
Figure 33. Americas Intelligent Clinical Trials Value Market Share by Country in 2025
Figure 34. United States Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 35. Canada Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 36. Mexico Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 37. Brazil Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 38. APAC Intelligent Clinical Trials Market Size Market Share by Region in 2025
Figure 39. APAC Intelligent Clinical Trials Market Size Market Share by Type (2021-2026)
Figure 40. APAC Intelligent Clinical Trials Market Size Market Share by Application (2021-2026)
Figure 41. China Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 42. Japan Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 43. South Korea Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 44. Southeast Asia Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 45. India Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 46. Australia Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 47. Europe Intelligent Clinical Trials Market Size Market Share by Country in 2025
Figure 48. Europe Intelligent Clinical Trials Market Size Market Share by Type (2021-2026)
Figure 49. Europe Intelligent Clinical Trials Market Size Market Share by Application (2021-2026)
Figure 50. Germany Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 51. France Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 52. UK Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 53. Italy Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 54. Russia Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 55. Middle East & Africa Intelligent Clinical Trials Market Size Market Share by Region (2021-2026)
Figure 56. Middle East & Africa Intelligent Clinical Trials Market Size Market Share by Type (2021-2026)
Figure 57. Middle East & Africa Intelligent Clinical Trials Market Size Market Share by Application (2021-2026)
Figure 58. Egypt Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 59. South Africa Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 60. Israel Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 61. Turkey Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 62. GCC Countries Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 63. Americas Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 64. APAC Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 65. Europe Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 66. Middle East & Africa Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 67. United States Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 68. Canada Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 69. Mexico Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 70. Brazil Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 71. China Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 72. Japan Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 73. Korea Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 74. Southeast Asia Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 75. India Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 76. Australia Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 77. Germany Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 78. France Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 79. UK Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 80. Italy Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 81. Russia Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 82. Egypt Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 83. South Africa Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 84. Israel Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 85. Turkey Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 86. Global Intelligent Clinical Trials Market Size Market Share Forecast by Type (2027-2032)
Figure 87. Global Intelligent Clinical Trials Market Size Market Share Forecast by Application (2027-2032)
Figure 88. GCC Countries Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 1. Intelligent Clinical Trials Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Intelligent Clinical Trials Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Intelligent Clinical Trials Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Intelligent Clinical Trials Sales Market Share by Country/Region (2025)
Figure 8. Intelligent Clinical Trials Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Intelligent Clinical Trials Market Size Market Share by Type in 2025
Figure 10. Intelligent Clinical Trials in Autoimmune/Inflammation
Figure 11. Global Intelligent Clinical Trials Market: Autoimmune/Inflammation (2021-2026) & ($ millions)
Figure 12. Intelligent Clinical Trials in Pain Management
Figure 13. Global Intelligent Clinical Trials Market: Pain Management (2021-2026) & ($ millions)
Figure 14. Intelligent Clinical Trials in Oncology
Figure 15. Global Intelligent Clinical Trials Market: Oncology (2021-2026) & ($ millions)
Figure 16. Intelligent Clinical Trials in Central Nervous System (CNS) Condition
Figure 17. Global Intelligent Clinical Trials Market: Central Nervous System (CNS) Condition (2021-2026) & ($ millions)
Figure 18. Intelligent Clinical Trials in Diabetes
Figure 19. Global Intelligent Clinical Trials Market: Diabetes (2021-2026) & ($ millions)
Figure 20. Intelligent Clinical Trials in Obesity
Figure 21. Global Intelligent Clinical Trials Market: Obesity (2021-2026) & ($ millions)
Figure 22. Intelligent Clinical Trials in Cardiovascular
Figure 23. Global Intelligent Clinical Trials Market: Cardiovascular (2021-2026) & ($ millions)
Figure 24. Intelligent Clinical Trials in Others
Figure 25. Global Intelligent Clinical Trials Market: Others (2021-2026) & ($ millions)
Figure 26. Global Intelligent Clinical Trials Market Size Market Share by Application in 2025
Figure 27. Global Intelligent Clinical Trials Revenue Market Share by Player in 2025
Figure 28. Global Intelligent Clinical Trials Market Size Market Share by Region (2021-2026)
Figure 29. Americas Intelligent Clinical Trials Market Size 2021-2026 ($ millions)
Figure 30. APAC Intelligent Clinical Trials Market Size 2021-2026 ($ millions)
Figure 31. Europe Intelligent Clinical Trials Market Size 2021-2026 ($ millions)
Figure 32. Middle East & Africa Intelligent Clinical Trials Market Size 2021-2026 ($ millions)
Figure 33. Americas Intelligent Clinical Trials Value Market Share by Country in 2025
Figure 34. United States Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 35. Canada Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 36. Mexico Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 37. Brazil Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 38. APAC Intelligent Clinical Trials Market Size Market Share by Region in 2025
Figure 39. APAC Intelligent Clinical Trials Market Size Market Share by Type (2021-2026)
Figure 40. APAC Intelligent Clinical Trials Market Size Market Share by Application (2021-2026)
Figure 41. China Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 42. Japan Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 43. South Korea Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 44. Southeast Asia Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 45. India Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 46. Australia Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 47. Europe Intelligent Clinical Trials Market Size Market Share by Country in 2025
Figure 48. Europe Intelligent Clinical Trials Market Size Market Share by Type (2021-2026)
Figure 49. Europe Intelligent Clinical Trials Market Size Market Share by Application (2021-2026)
Figure 50. Germany Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 51. France Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 52. UK Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 53. Italy Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 54. Russia Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 55. Middle East & Africa Intelligent Clinical Trials Market Size Market Share by Region (2021-2026)
Figure 56. Middle East & Africa Intelligent Clinical Trials Market Size Market Share by Type (2021-2026)
Figure 57. Middle East & Africa Intelligent Clinical Trials Market Size Market Share by Application (2021-2026)
Figure 58. Egypt Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 59. South Africa Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 60. Israel Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 61. Turkey Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 62. GCC Countries Intelligent Clinical Trials Market Size Growth 2021-2026 ($ millions)
Figure 63. Americas Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 64. APAC Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 65. Europe Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 66. Middle East & Africa Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 67. United States Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 68. Canada Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 69. Mexico Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 70. Brazil Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 71. China Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 72. Japan Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 73. Korea Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 74. Southeast Asia Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 75. India Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 76. Australia Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 77. Germany Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 78. France Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 79. UK Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 80. Italy Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 81. Russia Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 82. Egypt Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 83. South Africa Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 84. Israel Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 85. Turkey Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
Figure 86. Global Intelligent Clinical Trials Market Size Market Share Forecast by Type (2027-2032)
Figure 87. Global Intelligent Clinical Trials Market Size Market Share Forecast by Application (2027-2032)
Figure 88. GCC Countries Intelligent Clinical Trials Market Size 2027-2032 ($ millions)
More Publications
Global Porcelain Primer Market Growth 2023-2029
US$ 3,660.00
March 2023
74 pages
Global Childbirth Monitor Market Growth 2023-2029
US$ 3,660.00
January 2023
100 pages
Global Disposable Blood Dialyzer Market Growth 2023-2029
US$ 3,660.00
March 2023
105 pages
Global Metabolic Disorders Therapeutics Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
May 2024
106 pages
Global Adenosine Receptor A3 Market Growth 2024-2030
US$ 3,660.00
February 2024
76 pages
